NCT04426019 is a NA clinical trial of CLS Intervention in Breast Cancer, sponsored by The University of Texas Health Science Center, Houston.

Who is sponsoring NCT04426019?

NCT04426019 is sponsored by The University of Texas Health Science Center, Houston.

What drugs are being tested in NCT04426019?

Interventions in NCT04426019: CLS Intervention, No CLS intervention.

What condition does NCT04426019 study?

NCT04426019 studies Breast Cancer, Cervical Cancer.

Is NCT04426019 still recruiting?

NCT04426019 is currently completed. Last updated 12 October 2023.

Last reviewed 2023-10-12 · How we verify

NCT04426019

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Using a Lay Health Worker Program to Increase Breast and Cervical Cancer Screening in Low-Income Hispanic Women

Completed NA Last updated 12 October 2023

What this trial tests

NA trial testing CLS Intervention in Breast Cancer in 1,025 participants. Completed in 16 May 2014.

Timeline

12 January 2012

Primary endpoint
16 May 2014

16 May 2014

Quick facts

Lead sponsor	The University of Texas Health Science Center, Houston
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	1,025
Start date	12 January 2012
Primary completion	16 May 2014
Estimated completion	16 May 2014
Sites	1 location across United States

Drugs / interventions tested

CLS Intervention
No CLS intervention

Conditions studied

Breast Cancer — all drugs for Breast Cancer →
Cervical Cancer — all drugs for Cervical Cancer →

Sponsor

The University of Texas Health Science Center, Houston

Who can join

21 and older, female only, with Breast Cancer or Cervical Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary purpose of this study is adapt the Cultivando la Salud (CLS) intervention for a new community and priority population and to train community health workers (promotoras) from the Prosalud promotora program to implement the adapted CLS breast and cervical cancer screening program. The adaptation and delivery of the CLS intervention program focuses on meeting the needs and supporting of CHWs and Hispanic/Latina women in the Greater Houston Area. Finally, this study aims to evaluate the process and effect of the adapted CLS program (renamed Salud en Mis Manos (SEMM) on increasing mammography and cervical cancer screening.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A randomized controlled trial to evaluate an adapted community health worker-delivered breast and cervical cancer screening education and navigation intervention for underserved Latina adults.
Savas LS, Heredia NI, Huyan Y, Coan S, et al · · 2026 · PMID 41889398 · DOI 10.3389/fonc.2026.1687113

Verify or expand the search:

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

NCT04200729 — Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis: a Multi-cente · Phase 4 · not yet recruiting
NCT07225062 — Improving HIV Prevention and Substance Use Post-Sexual Assault Services · NA · not yet recruiting
NCT07396974 — Increasing Treatment Access in Trauma Exposed Children: Developing an Adapted Step One Intervention (RCT) · NA · not yet recruiting
NCT07170163 — Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families · NA · not yet recruiting
NCT06915441 — Lipid Infusions to Optimize Nutrition Trial · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04426019 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The University of Texas Health Science Center, Houston
Last refreshed: 12 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04426019.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing